DOD Biotech Public Company Limited reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was THB 170.54 million compared to THB 117.41 million a year ago. Revenue was THB 172.06 million compared to THB 122.48 million a year ago.

Net income was THB 0.259 million compared to net loss of THB 17.93 million a year ago. Basic earnings per share from continuing operations was THB 0.008 compared to basic loss per share from continuing operations of THB 0.035 a year ago. Basic earnings per share was THB 0.001 compared to basic loss per share of THB 0.044 a year ago.